Gaurav Kharya/LinkedIn
Jun 24, 2026, 16:49
Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
Gaurav Kharya, Director, Dept. of Bone Marrow Transplant and Cellular Therapy at Indraprastha Apollo Hospitals, shared a post on LinkedIn:
“Some issues cannot wait.
Access to safe blood for people who depend on regular transfusions is one of them-because delays can have life-threatening consequences.
My article in The Week looks at why ensuring timely and safe blood access remains critical, and why sustained attention and action are needed for those who rely on it every day.
Indraprastha Apollo Hospitals, New Delhi Cellogen Therapeutics
Bridging the gaps: Safe blood, lifesaving care, and a cure for sickle cell disease – The Week.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026